TFRC and neoplasm: A possible hypothesis to explain this notable difference in the in vivo efficacy of encapsulated MIT compared to free MIT, as well as a better tumor biodistribution [13], could be an increase in TfR1 expression on tumor cells due to hypoxic condition with HIF-1 increase [32].